Your browser doesn't support javascript.
loading
Mitochondrial respiratory chain activity is associated with severity, corticosteroid response and prognosis of alcoholic hepatitis.
Solís-Muñoz, Pablo; de la Flor-Robledo, María; García-Ruíz, Inmaculada; Fernández-García, Carlos E; González-Rodríguez, Águeda; Shah, Naina; Bataller, Ramón; Heneghan, Michael; García-Monzón, Carmelo; Solís-Herruzo, José A.
Afiliação
  • Solís-Muñoz P; Liver Research Unit, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa, Madrid, Spain.
  • de la Flor-Robledo M; Unidad Médica Angloamericana, Madrid, Spain.
  • García-Ruíz I; Gastroenterology and Hepatology Unit, Hospital Universitario Santa Cristina, Madrid, Spain.
  • Fernández-García CE; Facultad de Medicina, Universidad Francisco de Vitoria, Madrid, Spain.
  • González-Rodríguez Á; Anesthesiology Department, Hospital Universitario Severo Ochoa, Madrid, Spain.
  • Shah N; Gastroenterology and Hepatology Laboratory, Research Institute, University Hospital "12 de Octubre". Universidad Complutense, Madrid, Spain.
  • Bataller R; Liver Research Unit, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa, Madrid, Spain.
  • Heneghan M; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
  • García-Monzón C; Instituto de Investigaciones Biomédicas Alberto Sols (Centro Mixto CSIC-UAM), Madrid, Spain.
  • Solís-Herruzo JA; Institute of Liver Studies, King's College Hospital, London, UK.
Aliment Pharmacol Ther ; 57(10): 1131-1142, 2023 05.
Article em En | MEDLINE | ID: mdl-36864659
BACKGROUND AND AIMS: Little is known about the extent of mitochondrial respiratory chain (MRC) activity dysfunction in patients with alcoholic hepatitis (AH). We aimed to assess the hepatic MRC activity in AH patients and its potential impact on the severity and prognosis of this life-threatening liver disease. METHODS: MRC complexes were measured in liver biopsies of 98 AH patients (non-severe, 17; severe, 81) and in 12 histologically normal livers (NL). Severity was assessed according to Maddrey's Index and MELD score. Corticosteroid response rate and cumulative mortality were also evaluated. RESULTS: The activity of the five MRC complexes was markedly decreased in the liver of AH patients compared with that of NL subjects, being significantly lower in patients with severe AH than in those with non-severe AH. There was a negative correlation between the activity of all MRC complexes and the severity of AH. Interestingly, only complex I and III activities showed a significant positive correlation with the corticosteroid response rate and a significant negative correlation with the mortality rate at all-time points studied. In a multivariate regression analysis, besides the MELD score and the corticosteroid response rate, complex I activity was significantly associated with 3-month mortality (OR = 6.03; p = 0.034) and complex III activity with 6-month mortality (OR = 4.70; p = 0.041) in AH patients. CONCLUSION: Our results indicate that MRC activity is markedly decreased in the liver of AH patients, and, particularly, the impairment of MRC complexes I and III activity appears to have a significant impact on the clinical outcomes of patients with AH.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite Alcoólica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Aliment Pharmacol Ther Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite Alcoólica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Aliment Pharmacol Ther Ano de publicação: 2023 Tipo de documento: Article